Appropriate prescription, adherence and safety of non-steroidal anti-inflammatory drugs-Reference-Cited by-同舟云学术

Appropriate prescription, adherence and safety of non-steroidal anti-inflammatory drugs

Published:2016-03 Issue:6 Volume:146 Page:267-272
ISSN:2387-0206
Container-title:Medicina Clínica (English Edition)
language:en
Short-container-title:Medicina Clínica (English Edition)

Author:

Sostres Carlos,Lanas Ángel

Publisher

Elsevier BV

Subject

General Medicine

Reference30 articles.

1. New insights into the use of currently available non-steroidal anti-inflammatory drugs;Brune;J Pain Res,2015

2. Sratifying the risk of NSAID-related upper gastrointestinal clinical events: results of a double-blind outcomes study in patients with rheumatoid arthritis;Laine;Gastroenterology,2002

3. U. S. Food and Drug Administration. FDA news release; April 2005. FDA announces series of changes to the class of marketed non-steroidal anti-inflammatory drugs (NSAIDs) [accessed July 2010]. Available from: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2005/ucm108427.htm

4. Safe prescription recommendations for non steroidal anti-inflammatory drugs: consensus document ellaborated by nominated experts of three scientific associations (SER-SEC-AEG);Lanas;Gastroenterol Hepatol,2014

5. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee;Hochberg;Arthritis Care Res (Hoboken),2012

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NSAIDs, gastrointestinal toxicity and inflammatory bowel disease;Gastroenterología y Hepatología (English Edition);2022-03